1-（2-氨基苯基）-3-（3-硝基苯基）-2-丙烯-1-酮
| 中文名稱 | 1-（2-氨基苯基）-3-（3-硝基苯基）-2-丙烯-1-酮 |
|---|---|
| 中文同義詞 | 1-(2-氨基苯基)-3-(3-硝基苯基)丙-2-烯-1-酮;1-(2-氨基苯基)-3-(3-硝基苯基)-2-丙烯-1-酮 |
| 英文名稱 | 1-(2-Aminophenyl)-3-(3-nitrophenyl)-2-propen-1-one |
| 英文同義詞 | (2S)-3-[(2,5-Dihydro-5-oxoisoxazole)-2-yl]-2-aminopropanoic acid;β-(2,5-Dihydro-5-oxoisoxazole-2-yl)-L-alanine;2-Propen-1-one, 1-(2-aminophenyl)-3-(3-nitrophenyl)-;TMBIM6 antagonist-1;1-(2-Aminophenyl)-3-(3-nitrophenyl)prop-2-en-1-one;TMBIM-6 antagonist-1,TMBIM6 antagonist 1,HT1080,SKBR3,TMBIM6 antagonist1,MCF7,Mammalian target of Rapamycin,TMBIM6 antagonist-1,Ca2+,Inhibitor,inhibit,mTOR,TMBIM6;1-(2-Aminophenyl)-3-(3-nitrophenyl)-2-propen-1-one;BIA |
| CAS號 | 123134-61-2 |
| 分子式 | C15H12N2O3 |
| 分子量 | 268.27 |
| EINECS號 | |
| 相關(guān)類別 | 抑制劑 |
| Mol文件 | 123134-61-2.mol |
| 結(jié)構(gòu)式 |  |
1-（2-氨基苯基）-3-（3-硝基苯基）-2-丙烯-1-酮 性質(zhì)
| 沸點 | 482.1±45.0 °C(Predicted) |
|---|---|
| 密度 | 1.315±0.06 g/cm3(Predicted) |
| 儲存條件 | Store at -20°C |
| 溶解度 | 二甲基亞砜：50 mg/mL（186.38 mM） |
| 形態(tài) | 固體 |
| 酸度系數(shù)(pKa) | -0.47±0.10(Predicted) |
| 顏色 | 淺黃至黃色 |
TMBIM6 antagonist-1 是一個有潛力的 TMBIM6 拮抗劑，抑制 TMBIM6 與 mTORC2 結(jié)合，降低 mTORC2 活性，調(diào)節(jié)TMBIM6 釋放 Ca2+。
TMBIM6 antagonist-1 (BIA, 0.5-10 μM, 3 days) significantly and dose-dependently inhibits cell viability in HT1080, MCF7, MDA-MB-2341 and SKBR3 cells, with IC
50
values of 1.7?±?0.1?μM for HT1080, 2.6?±?0.4?μM for MCF cells, 2.6?±?0.5?μM for MDA-MB-231 cells, and 2.4?±?0.4?μM for SKBR3 cells, respectively.
TMBIM6 antagonist-1 (BIA, 10 μM) treatment decreases cell migration in HT1080, MCF7, MDA-MB-231, and SKBR3 cells, not TMBIM6 KO HT1080 cells.
Cell Viability Assay
| Cell Line: | HT1080, MCF7, MDA-MB-2341 and SKBR3 cells. |
| Concentration: | 0.5-10 μM. |
| Incubation Time: | 3 days. |
| Result: | Inhibited cell viability. |
Western Blot Analysis
| Cell Line: | WT and TMBIM6 KO HT1080 cells. |
| Concentration: | 0, 2, 5 μM. |
| Incubation Time: | |
| Result: | Downregulated the protein levels of AKT-pS473. |
TMBIM6 antagonist-1 (1?mg/kg, IP 5 days per week during 25 days) significantly impaires cell-driven tumor growth.
| Animal Model: |
Six- to eight-week BklNbt:BALB/c/nu/nu old mice (HT1080 and MDA-MB-231 cells).
|
| Dosage: | 1?mg/kg. |
| Administration: | IP 5 days per week during 25 days. |
| Result: | Impaired cell-driven tumor growth. |
安全信息
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-137175 | 1-（2-氨基苯基）-3-（3-硝基苯基）-2-丙烯-1-酮 TMBIM6 antagonist-1 | 123134-61-2 | 1 mg | 830元 |
| 2026/06/05 | HY-137175 | 1-（2-氨基苯基）-3-（3-硝基苯基）-2-丙烯-1-酮 TMBIM6 antagonist-1 | 123134-61-2 | 5mg | 1950元 |